Award recordCONTRACT

AURINIA PHARMA US INC

PIID 36E79721A0010· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2021· $0 net obligations· UEI Y394MPDW6GH4· MD

Description

BPA CANCELLATION DUE TO FSS INTERIM AGREEMENT EXPIRATION ON 07/31/2021.

Base award description: BPA FOR LUPKYNIS

First action · last action
2021-03-08 · 2021-07-26
Transactions
2
First transaction's obligation
$0
Base + all options value (sum of deltas)
$10,000,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79721D019E
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2021-03-08 · this action $0 · running total $0Modification P00001 · 2021-07-26 · this action $0 · running total $0
  • Base2021-03-08+$0= $0
  • Mod P000012021-07-26+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-03-08+$0$0BPA FOR LUPKYNIS
Mod P00001· LEGAL CONTRACT CANCELLATION2021-07-26+$0$0BPA CANCELLATION DUE TO FSS INTERIM AGREEMENT EXPIRATION ON 07/31/2021.

Related awards · 9

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI Y394MPDW6GH4)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0022NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79721A0019NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2021
36F79721D0217NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2021
36F79721D019ENAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2021

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0042GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79721A0010_3600 · retrieved 2026-09-26.